SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001213900-19-016952
Filing Date
2019-08-29
Accepted
2019-08-29 16:49:10
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-3 ff32019a1_therapixbio.htm F-3/A 281060
2 AMENDED AND RESTATED DEPOSITARY AGREEMENT DATED MARCH 21, 2017 ff32019a1ex4-2_therapix.htm EX-4.2 272787
3 CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL ff32019a1ex23-1_therapix.htm EX-23.1 4211
4 GRAPHIC img_001.jpg GRAPHIC 16482
5 GRAPHIC ex23-1_001.jpg GRAPHIC 5841
  Complete submission text file 0001213900-19-016952.txt   590117
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-233417 | Film No.: 191066917
SIC: 2834 Pharmaceutical Preparations